Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Stock Awards Excluded from the Computation of the Effect of Dilutive Securities (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)		10		10
Stock Appreciation Rights (SARs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	1,027	1,041	1,027	1,041
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	1,230	1,747	1,230	1,747
Performance Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)		188		188
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	2,257	2,986	2,257	2,986